London Pharmacy Oncology Education evening: “CAR-T Cell Therapy”

We are delighted to invite you to the next London Pharmacy Oncology Education evening on Wednesday 1st May, at the Royal Marsden Education & Conference centre, Stewart’s Grove, Chelsea, SW3 6JJ.
 
The aim of this meeting is to provide clinical and practice updates for all levels of pharmacists and technicians with an interest in oncology or haematology, as well as providing the perfect opportunity to share ideas and best practice.
 
At this “CAR-T Cell Therapy” meeting you will learn about:
 
 6.30pm Overiew of CAR-T Cell Therapy
Dr Emma Nicholson, Consultant Haematologist, The Royal Marsden NHS Foundation Trust
 
• 7pm Pharmacy Governance Issues & Commissioning, Patient Case Study
Nisha Shaunak , Lead Pharmacist for Oncology, Guy’s and St Thomas’ & Specialised Cancer Commissioning Pharmacist, NHS England (London region)
Jackie Chappell, Consultant Pharmacist, Haematology/ATMPs, King’s College Hospital NHS Foundation Trust
 
• 7.30pm Experience & Impact of first CAR-T trial patient
Annette Musallam, Lead Pharmacist Clinical Research & Development, The Royal Marsden NHS Foundation Trust
 
Refreshments and a light buffet will be provided from 6.00pm, in the conservatory area on the ground floor. The meeting will start at 6.30pm in the Julian Bloom Lecture Theatre, on the 1st floor. Please see the map included with this invitation, which shows the location of Royal Marsden Education & Conference centre.
 
Please register here https://www.eventbrite.com/e/london-pharmacy-oncology-education-evening-car-t-cell-therapy-tickets-57115627379 by Monday 22nd April, to enable us to plan effectively for this meeting.
 
If you register for this event and then find closer to the time that you cannot attend, please cancel your booking via the website or contact me directly ([email protected]).
 
Please pass on to all you colleagues who may be interested in attending and look forward to seeing you all there.
Best wishes
Anita
 
Anita McWhirter
New Models of Care Pharmacist
The Royal Marsden NHS Foundation Trust
 

Latest News

By BOPA Research Committee on 27th April 2025

SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment

Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…

Read article
By BOPA on 27th April 2025

Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…

Read article
By BOPA Committee on 27th April 2025

Women for Oncology UK Spring Webinar

The Spring webinar for Women for Oncology UK is on the 16th May, to sign up click the link below. Women For Oncology UK Spring Webinar Tickets, Wed 14 May…

Read article
By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article